Are You Making These Dangerous Investment Mistakes? Click Here to Read Our Special Report



Geron Stock Quote
$1.72 -$0.01 -0.6%
Price as of August 5, 2020, 4:30 p.m. EDT View Interactive GERN Charts

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.

Interactive Chart

News & Analysis: Geron

The Fool has written over 300 articles on Geron.


Market Moves



Why Geron Stock Soared 23.4% Today

The bio pharmaceutical announced fresh data on imetelstat that it will present at a key conference next month.

Better Buy: Geron vs. Incyte

Formed in the early ‘90s, Geron and Incyte exemplify the long and often tumultuous road it takes to translate science into medicines.